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Bone is a dynamic tissue which provides mechanical support for stature and locomotion, protects vital organs, and acts as a metabolic organ which controls mineral 
homeostasis. In order to carry out these important functions, bone is subjected to modeling and remodeling process. Bone modeling is responsible for both the growth and the 
mechanical adaption of the bone. Conversely, bone remodeling involves the removal of old or damaged bone tissue, a process that is mediated by osteoclast (bone resorption) 
and subsequent replacement of new bone formed, which is mediated by osteoblasts (bone formation).  
 
Physiological bone remodeling requires a tight coupling between bone resorption and bone formation to  maintain the equilibrium and to guarantee that there is no alteration in 
bone mass or quality after each remodeling cycle. The remodeling process takes place within functionally and anatomically distinct sites termed basic multicellular units. These 
basic multicellular units require a strictly coordinated and synchronized action of the main types of bone cells: bone-lining cells, osteocytes, osteoblasts and osteoclasts. 
Moreover, a balance between bone resorption and bone remodeling is controlled by different molecular mechanisms, such as multiple signaling pathways. Nonetheless, an 
increase in osteoclast activity may occur under certain bone pathological conditions, so therapies that inhibit osteoclast, such as bisphosphonates, are effective at preventing 
bone loss. Therefore, these drugs are exploited in the development of new therapies for osteoporosis and other metabolic bone diseases.  
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Figure 1. Intracellular signaling pathways implicated in osteoblastogenesis 
Osteoblasts following timely programmed steps requiring the expression of specific 
transcription factors, such as Runx2, Dlx5 i Osx. In turn, the expression and activity of 
these factors is under the control of multiple pro-osteogenic signaling pathways, such as 
bone morphogenetic proteins (BMPs), Wnt/β-catenin and Notch pathways.  
These pathways are crucial especially in the early steps of osteoblastogenesis. The 
interplay between BMP and Wnt/β-catenin signaling affects bone formation. The signaling 
cascade activated by interaction between BMP and their receptors activates the 
transcription of genes which encode DKK and Sost, two inhibitors of Wnt/β-catenin 
signaling. Furthermore, activation of Notch signaling pathway could inhibit the transcription 
of Runx2 directly or indirectly. Therefore, this signaling pathway could suppress 
osteoblastogenic induced by BMP and Wnt.  
 
 
Figure 2. Role of connexin 43 hemichannels (Cx43) and Wnt/β-
catenin signaling pathway in osteocyte function and viability 
Expression of Cx43 in osteocytes is regulated by β-catenin, which has 
been shown to bind to Cx43 promoter, stimulating Cx43 expression and 
functional gap junctions between osteocytes. Therefore, the expression 
of Cx3 and Wnt/β-catenin signaling pathway play a role not only in 
osteocyte viability in response to shear stress or loading, but also in 
osteocyte apoptosis, so that their absence leads to cell apoptosis. In 
this sense, osteocytes apoptosis positively regulate osteoclast function 
and differentiation, and the same parameters are negatively regulated 
in osteoblast by osteocytes. 
Figure 3. Regulation of osteoclasts differentiation and function by 
osteoblasts, through the RANKL/RANK/OPG pathway 
Osteoclasts are members of the monocyte/macrophage lineage and are 
formed by multiple cellular fusions from their mononuclear precursors. Their 
differentiation is regulated by a number of other cells, as osteoblasts and 
their secreted products, especially by monocyte/macrophage colony-
stimulating factor (M-CSF) and receptor activator of NF-kB ligand (RANKL). 
Osteoblasts also produce another factor called osteoprotegerin (OPG), a 
soluble protein that inhibits osteoclastogenesis and the subsequent bone 
resorption by binding to RANKL and avoiding its interaction with receptor 
activator of NF-kB (RANK).  
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Bisphosphonates  (BPs) 
 Chemically stable analogues of 
inorganic pyrophosphate Mechanism of action on osteoclasts 
1.   Preferential binding into mineral surface of the bone 
2.   Concentration in areas of active remodeling  
3. Internalization (endocytosis) into cytoplasm of osteoclasts 
      by bone-resorbing osteoclast by endocytosis  
4.   Release the into cytosol of osteoclasts  
5.   Biochemical effect: inhibition of prenylated Rab GTPases 
      proteins   
6.   Cellular effect: osteoclast’s inactivation or apoptosis     
BPs simples 
(clodronate or etidronate)  
Non-nitrogen containing in chemical structure 
N-BPs 
(alendronate, risedronate or zoledronate)  
Nitrogen-containing in chemical structure 
Mechanism of action on osteocytes/osteoblasts 
1.   Access to osteocytes by extracellular fluid of canalicular 
      compartment  
2.   Opening of the connexin 43 hemichannels 
3.   Activation of extracellular signal-regulated kinases (ERKs) 
      that fosforilate their targets.  
5.   Inhibit apoptosis in osteocytes and osteoblasts 
4.   ERKs activate anti-apoptotic pathways 
Metabolized in the 
osteoclast cytosol  
Mevalonate 
Prenylated Rab GTPases proteins 
required for osteoclast function 
and survival 
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Figure 4. Ultrastructure and function of osteoclasts 
The resorbing osteoclasts are polarized and reorganize their membrane into specific 
and distinct membrane domains: the functional secretory domain, the basolateral 
domain, the sealing zone, and ruffled border. Polarization and bone resorption need a 




1. Raggatt LJ, Partridge NC. Cellular and molecular mechanisms of bone 
remodeling. J Biol Chem 2010: 285 (33): 25103-8.  
2. Issack PS, Helfet DL, Lane JM. Role of Wnt Signaling in Bone Remodeling and 
Repair. HSSJ 2008; 4: 66-70.  
3. Bonewald LF, Johnson ML. Osteocytes, mechanosensing and Wnt signaling. 
Bone 2008; 42(4): 606-15. 
4. Coxon FP, Taylor A. Vesicular trafficking in osteoclasts. Semin Cell Dev Biol 
2008; 19(5): 424-33.  
5. Rusell RGG, Watts NB, Ebetino FH, Rogers MJ. Mechanisms of action of 
bisphosphinates: similarities and differences and their potential influence on 
clinical efficacy. Osteoporos Int 2008; 19: 733-759. 
 
References 
The aims of this review are: 
 To discuss in depth the cellular and molecular mechanisms of bone remodeling. 
 To confirm and understanding of the cellular and biochemical effects that bisphosphonates could have into bone cells.  
 In order to maintain the balance between bone resorption and forming, the main types of bone cells act in a synchronized way, which requires different molecular control 
mechanisms and multiple intracellular signaling pathways, among which RANKL/RANK/OPG and Wnt/β-catenin are the most important ones.  
 Any alteration of the strict equilibrium in bone remodeling involves the development of bone pathologies, which highlight the need of using pharmacological therapies to 
treat these pathologies.  
 Alterations in the function and regulation of osteoclasts, especially, have been shown in multiple bone pathologies, such as osteoporosis. Currently, the most widely used 
and effective drugs against bone resorption are bisphosphonate.  
 Nowadays, although a possible mechanism of action for bisphosphonates on osteoclasts is known, it remains unclear if it could also act on other alternative pathways to 
modulate bone remodeling profits or losses.  
 As the exact mechanism has not yet been elucidated, there is a need for studying the potential interactions between bisphosphonates and osteocytes or osteoblasts. 
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